POLD1 and cancer: Accurate POLE and POLD1 ED variant classification, which is the focus of this article, is of utmost importance due to the consequences for the correct clinical management of ED variant heterozygotes and their families, impacting clinical surveillance based on specific cancer risks, as well decision making in oncology, based on the predictive value of ED mutations for prognosis and response to immunotherapy.